WAPNICK PAMELA (Chief Financial Officer) sold 2.1% of their position (1.58K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/9/2025ACC: 0000950170-25-083949
Officer· Chief Financial Officer
Since Mar 2026
-1.58K
Net shares
Net seller
$2.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.58K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.58K
Price / share
$1.75
Trade value
$2.76K
% of position
2.1%
6/6/2025
73.68K→72.11K
Total
Net shares
−1.58K
Net value
-$2.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/6/2025 | S · Sale | −1.58K | $1.75 | $2.76K | 2.1% | 73.68K | 72.11K |
| Total | −1.58K | -$2.76K | ||||||
Derivative Transactions0
No derivative transactions reported